Analgesics (Pharmacies) - Myanmar

  • Myanmar
  • Revenue in the Analgesics market is projected to reach US$30.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.24%, resulting in a market volume of US$45.16m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.55 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Myanmar has been growing steadily over the past few years.

Customer preferences:
Customers in Myanmar have shown a growing demand for analgesics, particularly in pharmacies. This can be attributed to several factors. Firstly, there is a rise in the awareness and understanding of the importance of pain management among the population. As people become more health-conscious, they are seeking ways to alleviate pain and discomfort. Secondly, the increasing availability of analgesics in pharmacies has made it easier for customers to access these products. Pharmacies are considered a trusted source for medication, and customers feel more confident in purchasing analgesics from these establishments.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Myanmar is the growing popularity of over-the-counter (OTC) analgesics. OTC analgesics are medications that can be purchased without a prescription, and they offer convenience to customers who may not have immediate access to healthcare professionals. This trend is driven by the increasing number of self-medication practices in the country. Customers are more inclined to treat minor aches and pains themselves, rather than seeking medical advice. As a result, the demand for OTC analgesics in pharmacies has been on the rise. Another trend in the market is the introduction of innovative analgesic products. Pharmaceutical companies are constantly developing new formulations and delivery methods to cater to the evolving needs of customers. For example, there has been a growing demand for fast-acting analgesics that provide quick relief from pain. Manufacturers have responded to this demand by introducing products with faster absorption rates and targeted pain relief mechanisms. These innovative products have gained popularity among customers and have contributed to the growth of the market.

Local special circumstances:
Myanmar has a unique market landscape that influences the development of the Analgesics (Pharmacies) market. The country has a large rural population with limited access to healthcare facilities. As a result, pharmacies play a crucial role in providing essential healthcare products, including analgesics, to these underserved areas. The demand for analgesics in rural areas is particularly high due to the lack of alternative pain management options. This has created opportunities for pharmacies to expand their reach and cater to the needs of the rural population.

Underlying macroeconomic factors:
The growing Analgesics (Pharmacies) market in Myanmar can be attributed to several macroeconomic factors. Firstly, the country has experienced significant economic growth in recent years, leading to an increase in disposable income. As a result, consumers have more purchasing power, which has contributed to the growth of the market. Additionally, the government has implemented policies to improve access to healthcare services, including the availability of essential medications in pharmacies. These initiatives have further fueled the demand for analgesics in the country. In conclusion, the Analgesics (Pharmacies) market in Myanmar is experiencing steady growth due to customer preferences for pain management, the popularity of OTC analgesics, the introduction of innovative products, the special circumstances of the local market, and underlying macroeconomic factors. As the market continues to evolve, it is expected to present new opportunities for both local and international players in the pharmaceutical industry.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)